415 related articles for article (PubMed ID: 16525350)
1. Lipopolysaccharide-induced tumor necrosis factor alpha production and not monocyte human leukocyte antigen-DR expression is correlated with survival in septic trauma patients.
Ploder M; Pelinka L; Schmuckenschlager C; Wessner B; Ankersmit HJ; Fuerst W; Redl H; Roth E; Spittler A
Shock; 2006 Feb; 25(2):129-34. PubMed ID: 16525350
[TBL] [Abstract][Full Text] [Related]
2. Effect of granulocyte-macrophage colony-stimulating factor on the immune response of circulating monocytes after severe trauma.
Flohé S; Lendemans S; Selbach C; Waydhas C; Ackermann M; Schade FU; Kreuzfelder E
Crit Care Med; 2003 Oct; 31(10):2462-9. PubMed ID: 14530752
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal monocyte human leukocyte antigen-DR expression is a prognostic marker in critically ill patients with decompensated liver cirrhosis.
Berres ML; Schnyder B; Yagmur E; Inglis B; Stanzel S; Tischendorf JJ; Koch A; Winograd R; Trautwein C; Wasmuth HE
Liver Int; 2009 Apr; 29(4):536-43. PubMed ID: 18795898
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of monocyte histocompatibility leukocyte antigen-DR expression and plasma interleukin-4 and -10 levels in critically ill patients with sepsis.
Hynninen M; Pettilä V; Takkunen O; Orko R; Jansson SE; Kuusela P; Renkonen R; Valtonen M
Shock; 2003 Jul; 20(1):1-4. PubMed ID: 12813360
[TBL] [Abstract][Full Text] [Related]
5. Immunological status of septic and trauma patients. I. High tumor necrosis factor alpha serum levels in septic and trauma patients are not responsible for increased mortality; a prognostic value of serum interleukin 6.
Adamik B; Zimecki M; Właszczyk A; Kübler A
Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):169-75. PubMed ID: 9597083
[TBL] [Abstract][Full Text] [Related]
6. Immunological status of septic and trauma patients. II. Proliferative response and production of interleukin 6 and tumor necrosis factor alpha by peripheral blood mononuclear cells from septic survivor, nonsurvivor and trauma patients: a correlation with the survival rate.
Adamik B; Zimecki M; Właszczyk A; Kübler A
Arch Immunol Ther Exp (Warsz); 1997; 45(4):277-84. PubMed ID: 9523001
[TBL] [Abstract][Full Text] [Related]
7. Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: Correlation with severity and secondary septic shock.
Venet F; Tissot S; Debard AL; Faudot C; Crampé C; Pachot A; Ayala A; Monneret G
Crit Care Med; 2007 Aug; 35(8):1910-7. PubMed ID: 17568330
[TBL] [Abstract][Full Text] [Related]
8. Suppression and recovery of LPS-stimulated monocyte activity after trauma is correlated with increasing injury severity: a prospective clinical study.
Wutzler S; Maier M; Lehnert M; Henrich D; Walcher F; Maegele M; Laurer H; Marzi I
J Trauma; 2009 May; 66(5):1273-80. PubMed ID: 19430226
[TBL] [Abstract][Full Text] [Related]
9. A comparison of monocyte counts and ex vivo and in vitro monocyte cytokine production after major surgical trauma.
Franke A; Lante W; Kollig E; Markewitz A
J Surg Res; 2009 Jun; 154(1):91-8. PubMed ID: 18952234
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of interleukin-10 mRNA expression in peripheral leukocytes predicts poor outcome and diminished human leukocyte antigen-DR expression on monocytes in septic patients.
Abe R; Hirasawa H; Oda S; Sadahiro T; Nakamura M; Watanabe E; Nakada TA; Hatano M; Tokuhisa T
J Surg Res; 2008 Jun; 147(1):1-8. PubMed ID: 17720196
[TBL] [Abstract][Full Text] [Related]
11. Expression of monocyte human leukocyte antigen-DR in relation with sepsis severity and plasma mediators.
Payen D; Faivre V; Lukaszewicz AC; Villa F; Goldberg P
Minerva Anestesiol; 2009 Sep; 75(9):484-93. PubMed ID: 19644434
[TBL] [Abstract][Full Text] [Related]
12. Lactoferrin effects on the in vitro immune response in critically ill patients.
Adamik B; Zimecki M; Właszczyk A; Berezowicz P; Kübler A
Arch Immunol Ther Exp (Warsz); 1998; 46(3):169-76. PubMed ID: 9704149
[TBL] [Abstract][Full Text] [Related]
13. The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration.
Monneret G; Finck ME; Venet F; Debard AL; Bohé J; Bienvenu J; Lepape A
Immunol Lett; 2004 Sep; 95(2):193-8. PubMed ID: 15388260
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of in vitro cytokine production by monocytes during sepsis.
Munoz C; Carlet J; Fitting C; Misset B; Blériot JP; Cavaillon JM
J Clin Invest; 1991 Nov; 88(5):1747-54. PubMed ID: 1939659
[TBL] [Abstract][Full Text] [Related]
15. Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure.
Antoniades CG; Berry PA; Davies ET; Hussain M; Bernal W; Vergani D; Wendon J
Hepatology; 2006 Jul; 44(1):34-43. PubMed ID: 16799971
[TBL] [Abstract][Full Text] [Related]
16. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
[TBL] [Abstract][Full Text] [Related]
17. Low HLA-DR expression on CD14+ monocytes of burn victims with sepsis, and the effect of carbachol in vitro.
Yang HM; Yu Y; Chai JK; Hu S; Sheng ZY; Yao YM
Burns; 2008 Dec; 34(8):1158-62. PubMed ID: 18538934
[TBL] [Abstract][Full Text] [Related]
18. Differential toll-like receptor expression after ex vivo lipopolysaccharide exposure in patients with sepsis and following surgical stress.
Tsujimoto H; Ono S; Majima T; Efron PA; Kinoshita M; Hiraide H; Moldawer LL; Mochizuki H
Clin Immunol; 2006 May; 119(2):180-7. PubMed ID: 16517212
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide-cell interaction and induced cellular activation in whole blood of septic patients.
Salomao R; Brunialti MK; Kallás EG; Martins PS; Rigato O; Freudenberg M
J Endotoxin Res; 2002; 8(5):371-9. PubMed ID: 12537696
[TBL] [Abstract][Full Text] [Related]
20. Characterization of circulating monocytes expressing HLA-DR or CD71 and related soluble factors for 2 weeks after severe, non-thermal injury.
Walsh DS; Thavichaigarn P; Pattanapanyasat K; Siritongtaworn P; Kongcharoen P; Tongtawe P; Yongvanitchit K; Jiarakul N; Dheeradhada C; Pearce FJ; Wiesmann WP; Webster HK
J Surg Res; 2005 Dec; 129(2):221-30. PubMed ID: 16045935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
